Nu-Med Plus (NUMD) Times Interest Earned (2012 - 2025)
Nu-Med Plus (NUMD) reported Times Interest Earned of -$3.42 for Q4 2025, up 53.65% on a YoY basis from -$2.22 in Q4 2024, and up 35.87% sequentially from -$5.33 in Q3 2025.
Nu-Med Plus (NUMD) Times Interest Earned (2012 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 14 years of Times Interest Earned data on file, last reported at -$3.42 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned rose 53.65% year-over-year to -$3.42; the trailing twelve-month figure through Dec 2025 stood at -$6.77 (up 46.36% YoY), and the FY2025 full-year result was -$0.02, up 23.19% from the prior year.
- Times Interest Earned grew to -$3.42 in Q4 2025, from -$5.33 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.0 in Q4 2022 to a low of -$43.92 in Q4 2023.
- A 5-year average of -$12.8 and a median of -$12.44 in 2023 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned soared 99.98% in 2021 and slumped 1422214.41% in 2023, its largest moves.
- Tracing NUMD's Times Interest Earned over 5 years: stood at -$0.05 in 2021, then surged by 94.3% to -$0.0 in 2022, then tumbled by 1422214.41% to -$43.92 in 2023, then surged by 83.22% to -$7.37 in 2024, then surged by 53.65% to -$3.42 in 2025.
- Business Quant data shows NUMD's Times Interest Earned at -$3.42 in Q4 2025, -$5.33 in Q3 2025, and -$8.36 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 82.35 |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn | 5.36 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -2.90 |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | -3.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.42 |
| Sep 30, 2025 | -5.33 |
| Jun 30, 2025 | -8.36 |
| Mar 31, 2025 | -15.17 |
| Dec 31, 2024 | -7.37 |
| Sep 30, 2024 | -13.82 |
| Jun 30, 2024 | -12.86 |
| Mar 31, 2024 | -16.50 |
| Dec 31, 2023 | -43.92 |
| Sep 30, 2023 | -12.02 |
| Jun 30, 2023 | -18.50 |
| Mar 31, 2023 | -21.87 |
| Dec 31, 2022 | 0.00 |
| Dec 31, 2021 | -0.05 |
| Dec 31, 2020 | -228.31 |
| Sep 30, 2020 | -110.61 |
| Jun 30, 2020 | -224.93 |
| Mar 31, 2020 | -38.13 |
| Dec 31, 2019 | -13.75 |
| Sep 30, 2019 | -33.51 |